Frolkis JP, Pearce GL, Sprecher DL. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
Am J Cardiol 2004;
94:1310-2. [PMID:
15541255 DOI:
10.1016/j.amjcard.2004.07.122]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2004] [Accepted: 07/14/2004] [Indexed: 11/16/2022]
Abstract
Nonprescriptive factors, including patient adherence, can affect the fluctuations in low-density lipoprotein (LDL) cholesterol observed in the clinical setting. In 241 statin-treated patients, although drugs and doses remained fixed, 57% of patients initially successful in reaching LDL cholesterol targets showed subsequent increases in LDL cholesterol. Conversely, 60% of patients who initially failed to reach targets had subsequent reductions in LDL cholesterol, with nearly 1/3 eventually attaining their LDL cholesterol goals.
Collapse